190 related articles for article (PubMed ID: 33008658)
1. How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system.
Antonialli AZ; Bertolli E; de Macedo MP; Pinto CAL; Calsavara VF; Neto JPD
An Bras Dermatol; 2020; 95(6):691-695. PubMed ID: 33008658
[TBL] [Abstract][Full Text] [Related]
2. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
3. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
[TBL] [Abstract][Full Text] [Related]
4. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
5. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
[TBL] [Abstract][Full Text] [Related]
6. Is mitotic rate still useful in the management of patients with thin melanoma?
Tejera-Vaquerizo A; Pérez-Cabello G; Marínez-Leborans L; Gallego E; Oliver-Martínez V; Martín-Cuevas P; Arias-Santiago S; Aneiros-Fernández J; Herrera-Acosta E; Traves V; Herrera-Ceballos E; Nagore E
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2025-2029. PubMed ID: 28750139
[TBL] [Abstract][Full Text] [Related]
7. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
Isom C; Wheless L; Hooks MA; Kauffmann RM
JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
[TBL] [Abstract][Full Text] [Related]
8. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas.
Fidanzi C; Bevilacqua M; D'Erme AM; Morganti R; Viacava P; Manzo Margiotta F; Romanelli M; Dini V; Janowska A; Bagnoni G
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():215-220. PubMed ID: 37279633
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
11. More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
Weitemeyer MB; Helvind NM; Brinck AM; Hölmich LR; Chakera AH
J Surg Oncol; 2022 Mar; 125(3):498-508. PubMed ID: 34672372
[TBL] [Abstract][Full Text] [Related]
12. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
13. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
Kirkland EB; Zitelli JA
Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
[TBL] [Abstract][Full Text] [Related]
14. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in thin and thick melanoma.
Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
17. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
Appleton SE; Fadel Z; Williams JS; Bezuhly M
Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
[TBL] [Abstract][Full Text] [Related]
18. Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study.
Theile H; Moore J; Dunn N; Cossio D; Forristal CE; Green AC; Smithers BM
ANZ J Surg; 2020 Apr; 90(4):503-507. PubMed ID: 32162780
[TBL] [Abstract][Full Text] [Related]
19. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
